GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aurisco Pharmaceutical Co Ltd (SHSE:605116) » Definitions » Sale Of Investment

Aurisco Pharmaceutical Co (SHSE:605116) Sale Of Investment : ¥111 Mil (TTM As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Aurisco Pharmaceutical Co Sale Of Investment?

Aurisco Pharmaceutical Co's sale of investment for the three months ended in Sep. 2024 was ¥-648 Mil. It means Aurisco Pharmaceutical Co gained ¥-648 Mil from selling investments. Aurisco Pharmaceutical Co's sale of investment for the trailing twelve months (TTM) ended in Sep. 2024 was ¥111 Mil.

Compared with last quarter (¥758 Mil in Jun. 2024 ), Aurisco Pharmaceutical Co gained less money from selling investments in Sep. 2024 (¥-648 Mil).


Aurisco Pharmaceutical Co Sale Of Investment Historical Data

The historical data trend for Aurisco Pharmaceutical Co's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aurisco Pharmaceutical Co Sale Of Investment Chart

Aurisco Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial 201.45 52.97 96.81 50.26 0.03

Aurisco Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 0.48 758.26 -647.56

Aurisco Pharmaceutical Co Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥111 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aurisco Pharmaceutical Co Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Aurisco Pharmaceutical Co's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Aurisco Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Badu Industrial Park, Tiantai County, Zhejiang Province, Taizhou, CHN, 317200
Aurisco Pharmaceutical Co Ltd is engaged in production and sales of specialty APIs and pharmaceutical intermediates. The company's products include API's and Intermediates. Its products are supplied to Asia, Europe, America and Middle East through a well-established sales network.
Executives
Qiu Pei Jing Director
Zhao Zhen Ping senior management
Zhang Li Qin senior management

Aurisco Pharmaceutical Co Headlines

No Headlines